-
Journal of Surgical Oncology Dec 1985Sixty-eight patients at the University of Illinois, Cook County, and the West Side Veterans Administration hospitals underwent pelvic exenteration for advanced pelvic...
Sixty-eight patients at the University of Illinois, Cook County, and the West Side Veterans Administration hospitals underwent pelvic exenteration for advanced pelvic malignancies during the 15-year period from 1969 to 1984. Thirty-two had colorectal cancers, eleven cervical, seven bladder, and six vulvar; in twelve the cancers were in miscellaneous pelvic sites. Forty-five exenterations were done with intent to cure, and twenty-three for palliation of patients with bulky, necrotic tumors that had caused symptomatic fistulae, local sepsis, chronic bleeding, or severe localized pain. The total 30-day postoperative mortality was 4.4% (3/68). The 5-year survival rate of patients who underwent curative exenteration was 33% (median 27 months). Pelvic exenteration appears to be a feasible surgical procedure for a variety of advanced malignancies as well as for palliation of severely symptomatic patients.
Topics: Adult; Aged; Female; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Palliative Care; Pelvic Exenteration; Pelvic Neoplasms; Postoperative Complications; Prognosis; Retrospective Studies
PubMed: 2417058
DOI: 10.1002/jso.2930300409 -
ANZ Journal of Surgery May 2023
Topics: Humans; Splenosis; Pelvic Neoplasms; Splenic Diseases; Pelvis; Diagnosis, Differential; Splenectomy
PubMed: 36566491
DOI: 10.1111/ans.18218 -
International Journal of Gynecological... 2008Ganglioneuroma is a rare benign neurogenic tumor originating from the sempathoadrenal nervous system and is considered the benign counterpart of neuroblastoma, lacking...
Ganglioneuroma is a rare benign neurogenic tumor originating from the sempathoadrenal nervous system and is considered the benign counterpart of neuroblastoma, lacking the immature neuroblastic cells. A case of pelvic ganglioneuroma is described.
Topics: Female; Follow-Up Studies; Ganglioneuroma; Humans; Hysterectomy; Immunohistochemistry; Magnetic Resonance Imaging; Middle Aged; Neoplasm Staging; Ovariectomy; Pelvic Neoplasms; Retroperitoneal Space; Risk Assessment; Tomography, X-Ray Computed; Treatment Outcome
PubMed: 17764452
DOI: 10.1111/j.1525-1438.2007.01047.x -
Archivos Espanoles de Urologia Apr 2014
Topics: Abdominal Pain; Adult; Female; Humans; Magnetic Resonance Imaging; Myxoma; Neoplasm Invasiveness; Pelvic Neoplasms; Tomography, X-Ray Computed
PubMed: 24840595
DOI: No ID Found -
Journal of Nuclear Medicine : Official... Feb 1984Extramedullary hematopoiesis is an infrequent cause of thoracic masses. Extrathoracic locations are even less common. We have studied two patients, one with suspected...
Extramedullary hematopoiesis is an infrequent cause of thoracic masses. Extrathoracic locations are even less common. We have studied two patients, one with suspected pelvic neoplasm, with technetium-99m sulfur colloid marrow image and transmission computerized tomography. This noninvasive evaluation established the diagnosis of pelvic extramedullary hematopoiesis in both. We recommend a similar diagnostic approach in patients with chronic anemia or other predisposing disease, presenting with a pelvic or abdominal mass.
Topics: Adult; Anemia, Sickle Cell; Bone Marrow; Female; Hematopoiesis; Humans; Mediastinal Neoplasms; Mediastinum; Middle Aged; Pelvic Neoplasms; Pelvis; Sulfur; Technetium; Technetium Tc 99m Sulfur Colloid; Thalassemia; Tomography, Emission-Computed
PubMed: 6610033
DOI: No ID Found -
European Journal of Surgical Oncology :... Dec 2023Chronic fistulating pelvic sepsis is an uncommon complication of multimodal treatment of visceral pelvic tumours. Radical multi-visceral resection is reserved for...
BACKGROUND
Chronic fistulating pelvic sepsis is an uncommon complication of multimodal treatment of visceral pelvic tumours. Radical multi-visceral resection is reserved for patients with persistent, debilitating symptoms despite less invasive treatments and for which there is minimal published data. This study aimed to report the rates of morbidity and long-term sepsis control after pelvic exenteration for chronic fistulating pelvic sepsis.
METHODS
This retrospective cohort study was conducted at a high-volume pelvic exenteration referral centre. Patients who underwent pelvic exenteration for chronic fistulating pelvic sepsis between September 1994 and January 2023 after previous treatment for pelvic malignancy were included. Data relating to postoperative morbidity, mortality and the rate of recurrent pelvic sepsis or fistulae were retrospectively collected.
RESULTS
19 patients who underwent radical resection for chronic fistulating pelvic sepsis after previous pelvic cancer treatment were included. 11 patients were male (58 %) and median age was 62 years (range 42-79). Previously treated rectal (8 patients, 42 %), prostate (5, 26 %) and cervical cancer (5, 26 %) were most common. 18 patients (95 %) had previously received high-dose pelvic radiotherapy, and 14 (74 %) had required surgical resection. Total pelvic exenteration was performed in 47 % of patients, total cystectomy in 68 % and major pubic bone resection in 37 %. There was no intraoperative or postoperative mortality. Major complication rate was 32 %. 12-month readmission rate was 42 %. At last follow up, 74 % had no signs or symptoms of persisting pelvic sepsis.
CONCLUSIONS
Pelvic exenteration for refractory pelvic sepsis following treatment of malignancy is safe and effective in selected patients.
Topics: Humans; Male; Adult; Middle Aged; Aged; Female; Pelvic Neoplasms; Retrospective Studies; Pelvic Exenteration; Combined Modality Therapy; Sepsis; Rectal Neoplasms; Neoplasm Recurrence, Local; Postoperative Complications; Treatment Outcome
PubMed: 37879161
DOI: 10.1016/j.ejso.2023.107124 -
Best Practice & Research. Clinical... Oct 2009The evaluation of a pelvic mass, detected at routine ultrasound or in the context of having acute symptoms, requires certain methodical steps. It is necessary to... (Review)
Review
The evaluation of a pelvic mass, detected at routine ultrasound or in the context of having acute symptoms, requires certain methodical steps. It is necessary to diagnose the primary site or origin of the lesion; understand whether the lesion is an intra- or an extra-peritoneal lesion; distinguish whether the structure of interest is 'functional' and transitory or if we are dealing with a persistent mass; attempt to discriminate between the benign or malignant nature of the lesion; formulate a specific diagnosis; and furthermore, in the case of a possible malignant mass, define the stage of the disease process. Transvaginal ultrasonography is a dynamic and interactive examination and besides an analysis of the echostructure, and 'elasticity' of a pelvic mass, it also permits an assessment of site-specific pain in different pelvic areas, and an evaluation of the movement of the mass in relation to adjacent structures. All these 'dynamic' features, together with morphological and vascular parameters, are essential for making a correct diagnosis. The features of acute ovarian pathology including torsion are not discussed in detail here. This article will concentrate on the characterisation of pelvic masses that may be encountered by any examiner in the course of an assessment of the female pelvis.
Topics: Adnexal Diseases; Diagnosis, Differential; Female; Humans; Neoplasm Staging; Pelvic Neoplasms; Ultrasonography
PubMed: 19303367
DOI: 10.1016/j.bpobgyn.2009.02.002 -
Cancer Radiotherapie : Journal de La... 2014Extracranial stereotactic radiotherapy is booming. The development and spread of dedicated accelerators coupled with efficient methods of repositioning can now allow... (Review)
Review
Extracranial stereotactic radiotherapy is booming. The development and spread of dedicated accelerators coupled with efficient methods of repositioning can now allow treatments of mobile lesions with moderate size, with high doses per fraction. Intuitively, except for the prostate, pelvic tumours, often requiring irradiation of regional lymph node drainage, lend little to this type of treatment. However, in some difficult circumstances, such as boost or re-radiation, stereotactic irradiation condition is promising and clinical experiences have already been reported.
Topics: Brachytherapy; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Recurrence, Local; Organs at Risk; Pelvic Neoplasms; Radiosurgery; Radiotherapy Dosage
PubMed: 24792995
DOI: 10.1016/j.canrad.2014.03.011 -
Seminars in Ultrasound, CT, and MR Jun 2017Magnetic resonance imaging (MRI) is often "one stop shop" for evaluating female pelvic masses that helps in diagnosis, staging, and restaging of these tumors. A pelvic... (Review)
Review
Magnetic resonance imaging (MRI) is often "one stop shop" for evaluating female pelvic masses that helps in diagnosis, staging, and restaging of these tumors. A pelvic mass can arise from any tissue present within the pelvis. Although most masses in the female pelvis arise from the reproductive organs, masses may also arise from the gastrointestinal tract, urinary system, adjacent soft tissues, peritoneum, etc. It may not always be possible to determine the site of origin or distinguish these masses based on imaging characteristics. However, familiarity with the clinicopathologic and MRI features of most common pelvic masses helps in narrowing the differential diagnosis. Diagnosis of these masses needs a holistic approach as required for any tumor including clinical history, laboratory data, and imaging characteristics. We focus on MRI characteristics of commonly encountered pelvic masses. A compartmental imaging approach is discussed in this article that helps in identifying and characterizing these masses.
Topics: Diagnosis, Differential; Female; Humans; Magnetic Resonance Imaging; Neoplasm Staging; Pelvic Neoplasms; Pelvis
PubMed: 28705369
DOI: 10.1053/j.sult.2016.11.004 -
Journal of Surgical Oncology Apr 2015Management of retroperitoneal sarcomas presents technical and oncological challenges. Imaging is crucial for diagnosis and to define local tumor extent. Complete gross... (Review)
Review
Management of retroperitoneal sarcomas presents technical and oncological challenges. Imaging is crucial for diagnosis and to define local tumor extent. Complete gross resection at initial presentation is the best chance for cure, but there is controversy as to how this can be best achieved. There is a long-term risk of local recurrence, which is best treated with repeat resection if feasible. The roles of radiation and chemotherapy remain undefined.
Topics: Humans; Neoplasm Staging; Pelvic Neoplasms; Retroperitoneal Neoplasms; Sarcoma
PubMed: 25482329
DOI: 10.1002/jso.23840